A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • National Cancer Center Japan
  • National Cancer Center (26-A-4)
  • National Cancer Center (29-A-3)
  • National Cancer Center (2020-J-3)
  • Ministry of Health, Labour and Welfare
  • Japan Agency for Medical Research and Development (JP21ck0106625)
  • Japan Agency for Medical Research and Development (JP16ck0106084)
  • Japan Agency for Medical Research and Development (JP19ck0106354)

This publication has 20 references indexed in Scilit: